Inactive Instrument

Other languages Karo Pharma AB (publ)

Equities

KARO

SE0007464888

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Karo Healthcare AB acquired Rights to the OTC brand Proctosedyl from Bayer Aktiengesellschaft.	Mar. 05
Karo Healthcare AB acquired Topical Lamisil Business from Haleon UK Holdings Ltd.	Oct. 31
Karo Healthcare AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-09-21
Karo Healthcare AB agreed to acquire Topical Lamisil Business from Haleon UK Holdings Ltd. for approximately £240 million.	23-08-01
Karo Healthcare Announces Management Appointments	23-07-04
Karo Healthcare Limited Appoints Michael Kaltenborn as Chief Strategy Corporate Development Officer, Effective February 1, 2023	23-01-17
Karo Intressenter AB completed the acquisition of remaining 13.6% stake in Karo Pharma AB (OM : KARO).	22-11-23
Karo Pharma Files for Delisting from Nasdaq First North Growth Market	22-11-10
Karo Pharma Suitor Karo Intressenter Further Extends Takeover Acceptance Period	22-10-11
EQT-backed Karo Intressenter Starts Mandatory Redemption of Remaining Karo Pharma Shares	22-09-26
EQT-backed Karo Intressenter's $1.5 Billion Karo Pharma Takeover Becomes Unconditional	22-09-19
Point sur les fortes variations du jour : BHP porte les miniers, Sonova emportent tout le monde dans sa chute	22-08-16
Karo Pharma Lands $1.6 Billion Takeover Offer From EQT-controlled Shareholder	22-08-16
Karo Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-21
Karo Pharma to Raise $262 Million in Rights Issue	22-04-19
Reckitt Completes Sale of E45 Brand to Karo Pharma	22-04-01
Karo Pharma AB (OM:KARO) completed the acquisition of E45 brand and related sub-brands from Reckitt Benckiser Group plc.	22-03-31
Karo Pharma AB (OM:KARO) acquired Del Decus Enterprises Ltd.	22-03-27
Karo Pharma Receives Approvals For $265 Million Rights Issue, Change Of Listing To Nasdaq First North Growth Market	22-03-23
Nasdaq Stockholm Approves Delisting Application From Karo Pharma	22-03-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Karo Pharma AB (publ)

Equities

KARO

SE0007464888

Other languages

Filters